Alexander Mark Schobel Insider Trading $AQST Aquestive Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alexander Mark Schobel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alexander Mark Schobel. Alexander Mark Schobel is Chief Innovation/Tech Officer in Aquestive Therapeutics, Inc. ($AQST) and SVP,Chief Innov/Tech Officer in Aquestive Therapeutics, Inc. ($AQST).
Alexander Mark Schobel in Aquestive Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Alexander Mark Schobel: SVP,Chief Innov/Tech Officer, Chief Innovation/Tech Officer
Holdings: 860,460 shares
Latest Transaction: Feb 10 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Alexander Mark Schobel in Aquestive Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 2021 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Sell | S | 6.75 | 23,460 | 158,355 | 837,000 | 860.5 K to 837 K (-2.73 %) |
| Feb 10 2021 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Sell | S | 6.75 | 11,540 | 77,895 | 860,460 | 872 K to 860.5 K (-1.32 %) |
| Feb 09 2021 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Sell | S | 6.50 | 40,792 | 265,148 | 872,000 | 912.8 K to 872 K (-4.47 %) |
| Jun 02 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 14,572 | 0 | 0 | |
| Jun 02 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 4.87 | 4,132 | 20,123 | 912,553 | 916.7 K to 912.6 K (-0.45 %) |
| Jun 02 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 14,572 | 0 | 916,685 | 902.1 K to 916.7 K (+1.62 %) |
| May 04 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Sell | S | 4.00 | 40,000 | 160,000 | 942,113 | 982.1 K to 942.1 K (-4.07 %) |
| May 04 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Sell | S | 3.70 | 40,000 | 148,000 | 982,113 | 1 M to 982.1 K (-3.91 %) |
| May 01 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Sell | S | 4.50 | 40,000 | 180,000 | 1,022,113 | 1.1 M to 1 M (-3.77 %) |
| Apr 02 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 329 | 0 | 333 | |
| Apr 02 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 2.19 | 97 | 212 | 1,062,113 | 1.1 M to 1.1 M (-0.01 %) |
| Apr 02 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 329 | 0 | 1,062,210 | 1.1 M to 1.1 M (+0.03 %) |
| Mar 18 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | A | 1.54 | 70,000 | 107,800 | 70,000 | |
| Mar 18 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | A | 1.54 | 70,000 | 107,800 | 70,000 | |
| Mar 03 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 14,572 | 0 | 14,572 | |
| Mar 03 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 3.73 | 5,066 | 18,896 | 1,061,881 | 1.1 M to 1.1 M (-0.47 %) |
| Mar 03 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 14,572 | 0 | 1,066,947 | 1.1 M to 1.1 M (+1.38 %) |
| Dec 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 14,572 | 0 | 29,144 | |
| Dec 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 7.79 | 14,572 | 113,516 | 1,044,165 | 1.1 M to 1 M (-1.38 %) |
| Dec 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 14,572 | 0 | 1,058,737 | 1 M to 1.1 M (+1.40 %) |
| Oct 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 329 | 0 | 991 | |
| Oct 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 3.18 | 145 | 461 | 1,044,165 | 1 M to 1 M (-0.01 %) |
| Oct 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 329 | 0 | 1,044,310 | 1 M to 1 M (+0.03 %) |
| Sep 03 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 14,572 | 0 | 43,716 | |
| Sep 03 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 3.80 | 6,460 | 24,548 | 1,043,981 | 1.1 M to 1 M (-0.61 %) |
| Sep 03 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 14,572 | 0 | 1,050,441 | 1 M to 1.1 M (+1.41 %) |
| Jul 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 329 | 0 | 1,320 | |
| Jul 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 329 | 0 | 1,320 | |
| Jul 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 4.20 | 149 | 626 | 1,035,869 | 1 M to 1 M (-0.01 %) |
| Jul 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 4.20 | 149 | 626 | 1,035,869 | 1 M to 1 M (-0.01 %) |
| Jul 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 329 | 0 | 1,036,018 | 1 M to 1 M (+0.03 %) |
| Jul 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 329 | 0 | 1,036,018 | 1 M to 1 M (+0.03 %) |
| Jun 03 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 14,572 | 0 | 58,288 | |
| Jun 03 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 3.72 | 6,591 | 24,519 | 1,035,689 | 1 M to 1 M (-0.63 %) |
| Jun 03 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 14,572 | 0 | 1,042,280 | 1 M to 1 M (+1.42 %) |
| Apr 01 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 329 | 0 | 1,649 | |
| Apr 01 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 6.91 | 263 | 1,817 | 1,027,708 | 1 M to 1 M (-0.03 %) |
| Apr 01 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 329 | 0 | 1,027,971 | 1 M to 1 M (+0.03 %) |
| Mar 04 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | SVP,Chief Innov/Tec ... | Option Exercise | A | 8.05 | 75,000 | 603,750 | 75,000 | |
| Mar 01 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 14,572 | 0 | 72,860 | |
| Mar 01 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 8.05 | 6,721 | 54,104 | 1,027,642 | 1 M to 1 M (-0.65 %) |
| Mar 01 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 14,572 | 0 | 1,034,363 | 1 M to 1 M (+1.43 %) |
| Jan 03 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 329 | 0 | 1,978 | |
| Jan 03 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 6.30 | 162 | 1,021 | 1,019,791 | 1 M to 1 M (-0.02 %) |
| Jan 03 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 329 | 0 | 1,019,953 | 1 M to 1 M (+0.03 %) |
| Dec 11 2018 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | P | 7.78 | 1,000 | 7,780 | 1,019,624 | 1 M to 1 M (+0.10 %) |
| Dec 10 2018 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | P | 8.69 | 2,000 | 17,380 | 1,018,624 | 1 M to 1 M (+0.20 %) |
| Dec 04 2018 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 14,572 | 0 | 87,432 | |
| Dec 04 2018 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 8.59 | 7,177 | 61,650 | 1,016,624 | 1 M to 1 M (-0.70 %) |
| Dec 04 2018 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 14,572 | 0 | 1,023,801 | 1 M to 1 M (+1.44 %) |
| Nov 26 2018 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | P | 10.25 | 1,000 | 10,250 | 1,009,229 | 1 M to 1 M (+0.10 %) |
| Oct 02 2018 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 329 | 0 | 2,307 | |
| Oct 02 2018 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 17.51 | 162 | 2,837 | 1,008,229 | 1 M to 1 M (-0.02 %) |
| Oct 02 2018 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 329 | 0 | 1,008,391 | 1 M to 1 M (+0.03 %) |
| Sep 05 2018 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 14,572 | 0 | 102,004 | |
| Sep 05 2018 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 18.01 | 6,510 | 117,245 | 1,008,062 | 1 M to 1 M (-0.64 %) |
| Sep 05 2018 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 14,572 | 0 | 1,014,572 | 1000 K to 1 M (+1.46 %) |
| Aug 17 2018 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | A | 0.00 | 2,636 | 0 | 2,636 | |
| Aug 17 2018 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | A | 16.46 | 28,043 | 461,588 | 28,043 | |
| Jul 26 2018 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | A | 0.00 | 116,576 | 0 | 116,576 | |
| Jul 26 2018 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | A | 15.00 | 240,165 | 3,602,475 | 240,165 |
Page: 1